| ASSET | YEAR | % RETURN |
|---|---|---|
Reliance Global (EZRA) | 2018 | -99.31% |
Aytu BioScience (AYTU) | 2018 | -98.24% |
Digi Power X (DGXX) | 2018 | -97.89% |
Immunic (IMUX) | 2018 | -96.9% |
Theriva Biologics (TOVX) | 2018 | -96.81% |
Altimmune (ALT) | 2018 | -96.63% |
PDS Biotechnology (PDSB) | 2018 | -96.59% |
InspireMD (NSPR) | 2018 | -96.48% |
Galaxy Digital (GLXY) | 2018 | -96.25% |
Ocugen (OCGN) | 2018 | -95.69% |
Nutex Health (NUTX) | 2018 | -94.89% |
FabricAI (FABC) | 2018 | -94.75% |
Riot Platforms (RIOT) | 2018 | -94.7% |
Nextplat (NXPL) | 2018 | -94.67% |
Phio Pharmaceuticals (PHIO) | 2018 | -94.31% |
Azio AI (AZIO) | 2018 | -94.07% |
GameSquare (GAME) | 2018 | -93.56% |
Babcock & Wilcox Enterprises (BW) | 2018 | -93.15% |
BTCS (BTCS) | 2018 | -93.13% |
Celldex Therapeutics (CLDX) | 2018 | -92.98% |
Red Cat (RCAT) | 2018 | -92.86% |
HIVE Digital Technologies (HIVE) | 2018 | -92.78% |
PowerCompute (PWCM) | 2018 | -92.34% |
Rein Therapeutics (RNTX) | 2018 | -92.07% |
Achieve Life Sciences (ACHV) | 2018 | -91.71% |